Search Results - "Klomp, M."

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer by Klomp, M.J., Dalm, S.U., de Jong, M., Feelders, R.A., Hofland, J., Hofland, L.J.

“…Both somatostatin (SST) and somatostatin receptors (SSTRs) are proteins with important functions in both physiological tissue and in tumors, particularly in…”
Get full text

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial by VAN SCHIL, P. E, BAAS, P, GAAFAR, R, MAAT, A. P, VAN DE POL, M, HASAN, B, KLOMP, H. M, ABDELRAHMAN, A. M, WELCH, J, VAN MEERBEECK, J. P

“…The European Organisation for Research and Treatment of Cancer (EORTC; protocol 08031) phase II trial investigated the feasibility of trimodality therapy…”
Get full text

An approach to develop haptic feedback control reference for steering systems using open-loop driving manoeuvres by Chugh, T., Bruzelius, F., Klomp, M., Shyrokau, B.

“…In this paper, a methodology to capture the model-based haptic feedback control reference for closed-loop steering systems is demonstrated. The…”
Get full text

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients by Knijn, N, Mekenkamp, L J M, Klomp, M, Vink-Börger, M E, Tol, J, Teerenstra, S, Meijer, J W R, Tebar, M, Riemersma, S, van Krieken, J H J M, Punt, C J A, Nagtegaal, I D

“…Background: KRAS mutation is a negative predictive factor for treatment with anti-epidermal growth factor receptor antibody in metastatic colorectal cancer…”
Get full text

Longitudinal force distribution using quadratically constrained linear programming by Klomp, M.

“…In this paper, a new method is presented for the optimisation of force distribution for combined traction/braking and cornering. In order to provide a general,…”
Get full text

Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake by van den Berghe, Peter V E, Folmer, Dineke E, Malingré, Helga E M, van Beurden, Ellen, Klomp, Adriana E M, van de Sluis, Bart, Merkx, Maarten, Berger, Ruud, Klomp, Leo W J

“…High-affinity cellular copper uptake is mediated by the CTR (copper transporter) 1 family of proteins. The highly homologous hCTR (human CTR) 2 protein has…”
Get full text

Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer by SCHAAKE, Eva E, KAPPERS, Ingrid, CODRINGTON, Henk E, VALDES OLMOS, Renato A, TEERTSTRA, Hendrik J, PEL, Renée Van, BURGERS, Jacobus A, TINTEREN, Harm Van, KLOMP, Houke M

“…The development of targeted therapy has introduced new options to improve treatment outcome in selected patients. The objective of this prospective study was…”
Get full text

Improved identification of peripheral lung tumors by using diffuse reflectance and fluorescence spectroscopy by Spliethoff, Jarich W, Evers, Daniel J, Klomp, Houke M, van Sandick, Johanna W, Wouters, Michel W, Nachabe, Rami, Lucassen, Gerald W, Hendriks, Benno H.W, Wesseling, Jelle, Ruers, Theo J.M

“…Abstract Introduction A significant number of transthoracic diagnostic biopsy procedures for lung lesions show indeterminate results. Such failures are…”
Get full text

Management of large mediastinal masses: surgical and anesthesiological considerations by Li, Wilson W L, van Boven, Wim Jan P, Annema, Jouke T, Eberl, Susanne, Klomp, Houke M, de Mol, Bas A J M

“…Large mediastinal masses are rare, and encompass a wide variety of diseases. Regardless of the diagnosis, all large mediastinal masses may cause compression or…”
Get full text

Pre- and postoperative care for stage I–III NSCLC: which quality of care indicators are evidence-based? by Numan, Rachel C., PhD, Berge, Martijn Ten, PhD, Burgers, Jacobus A., MD, Klomp, Houke M., MD, van Sandick, Johanna W., MD, Baas, Paul, MD, Wouters, Michel W., MD

“…Highlights • Evidence-based quality indicators for the management of stage I–III NSCLC were identified. • The use of the PET-CT and invasive endoscopic…”
Get full text

COUNTERPOINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? No by Li, Wilson W., MD, Burgers, Jacobus A., MD, PhD, Klomp, Houke M., MD, PhD, Hartemink, Koen J., MD, PhD

Get full text

Outcome After Surgical Resections of Recurrent Chest Wall Sarcomas by WOUTERS, Michael W, VAN GEEL, Albert N, NIEUWENHUIS, Lotte, VAN TINTEREN, Harm, VERHOEF, Cees, VAN COEVORDEN, Frits, KLOMP, Houke M

“…Sarcomas of the chest wall are rare, and wide surgical resection is generally the cornerstone of treatment. The objective of our study was to evaluate outcome…”
Get full text

Diffuse Reflectance Spectroscopy: A New Guidance Tool for Improvement of Biopsy Procedures in Lung Malignancies by Evers, Daniel J, Nachabé, Rami, Klomp, Houke M, van Sandick, Johanna W, Wouters, Michel W, Lucassen, Gerald W, Hendriks, Benno H.W, Wesseling, Jelle, Ruers, Theo J.M

“…Micro-Abstract Procedural accuracy of percutaneous intrathoracic biopsies can be improved with diffuse reflectance spectroscopy (DRS). Normal and malignant…”
Get full text

Rebuttal From Dr Li et al by Li, Wilson W., MD, Burgers, Jacobus A., MD, PhD, Klomp, Houke M., MD, PhD, Hartemink, Koen J., MD, PhD

Get full text

Stage I non-small cell lung cancer: Treatment modalities, Dutch daily practice and future perspectives by Hopstaken, Jana S., de Ruiter, Julianne C., Damhuis, Ronald A.M., de Langen, Adrianus J., van Diessen, Judi N.A., Klomp, Houke M., Klompenhouwer, Elisabeth G., Hartemink, Koen J.

“…•Anatomical resection with lymph node dissection is recommended for stage i NSCLC.•Despite several trials, the role of SABR in operable patients is not clear…”
Get full text

Prognostic factors in infective endocarditis in general hospitals in the Netherlands by van den Brink, F., Hasenaar, J., Winia, V., Klomp, M., Van Vlies, B., Nicastia, D., Groenmeijer, B., Braam, R., Jaarsma, W., Funke Kupper, A. J.

“…Introduction Despite advances in treatment, infective endocarditis (IE) still ranks amongst the most lethal infectious diseases. We sought to determine…”
Get full text

Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer by Kappers, Ingrid, Klomp, Houke M, Burgers, Jacobus A, Van Zandwijk, Nico, Haas, Rick L M, van Pel, Renée

Get full text

FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC by van Gool, Matthijs H, Aukema, Tjeerd S, Hartemink, Koen J, Valdés Olmos, Renato A, van Tinteren, Harm, Klomp, Houke M

“…Over recent years,[18F]-fluorodeoxyglucose positron emission tomography acquired together with low dose computed tomography(FDG-PET/CT)has proven its role as a…”
Get full text

Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus by Blaauwgeers, Johannes L., Kappers, Ingrid, Klomp, Houke M., Belderbos, José S., Dijksman, Lea M., Smit, Egbert F., Postmus, Pieter E., Paul, Marinus A., Oosterhuis, Jan W., Hartemink, Koen J., Vos, Cornelis G., Burgers, Jacobus A., Dahele, Max, Phernambucq, Erik C., Witte, Birgit I., Thunnissen, Erik

“…The objective was to define the relationship between histopathological changes after pre-operative chemo-radiotherapy (CRT) and clinical outcome following…”
Get full text

Prognostic value of pre-operative glucose-corrected maximum standardized uptake value in patients with non-small cell lung cancer after complete surgical resection and 5-year follow-up by Konings, Renske, van Gool, Matthijs H., Bard, Martin P. L., Zwijnenburg, Anthonie, Titulaer, Bart M., Aukema, Tjeerd S., Valdés Olmos, Renato A., Sikorska, Karolina, Klomp, Houke M., Rijna, Herman

“…Introduction In this study we evaluated the value of pre-operative glucose corrected maximum standard uptake value (GC-SUVmax) as prognostic factor in patients…”
Get full text